Previous 10 | Next 10 |
home / stock / hmtxf / hmtxf news
Calgary, Alberta--(Newsfile Corp. - February 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce "Your Fountain of Youth" has been trademarked by the Company's intellectual property holding company, Kwalata Trading Limit...
Calgary, Alberta--(Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce a non-brokered private placement of up to 7,200,000 Units at $0.14 each for gross proceeds of up to $1,008,000 (the " Offering "). The O...
Calgary, Alberta--(Newsfile Corp. - January 21, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce it has signed a Global Master Services Agreement with My Next Health ("MNH"), and has, subject to TSXV approval, obtain...
Calgary, Alberta--(Newsfile Corp. - January 11, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce it has signed a contract with Dr. James Shapiro, University of Alberta, Edmonton and will complete a transfer ACP-01 to Dr. ...
Virtual Conference for Life Sciences Companies Broadcast Live December 16th Canada NewsWire Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , Dec. 14, 2021 /CNW/ - Virtual Investor Co...
Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com PR Newswire NEW YORK , Dec. 9, 2021 /PRNewswire/ -- Vi...
Calgary, Alberta--(Newsfile Corp. - December 9, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB :HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce the source document verification process has been completed and the Company has soft locked the HS 12-01 database. Next, eac...
Calgary, Alberta--(Newsfile Corp. - October 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce it is now up-listed to trade on the OTCQB under symbol HMTXF. The common shares of Hemostemix will continue to trade on the ...
Calgary, Alberta--(Newsfile Corp. - October 19, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce it filed with the compliance department of OTCQB all documentation required to up-list the Company's common shares on the OTCQ...
Calgary, Alberta--(Newsfile Corp. - October 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (" Hemostemix " or the " Company ") is pleased to announce the appointment of Dr. Fraser C. Henderson Sr., MD, as its Chief Medical Officer. Dr. Fraser C. Henderson Sr. is an exception...
News, Short Squeeze, Breakout and More Instantly...
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...